Negative impact of high body mass index on the efficacy of anti-TNFα agents in patients with Inflammatory Bowel Disease

被引:0
|
作者
Hamoir, F. [1 ]
De Leuze, F. [1 ]
Denis, M. [1 ]
De Vroey, B. [1 ]
De Suray, N. [1 ]
Burnet, G. [1 ]
Piessevaux, H. [1 ]
Dewit, O. [1 ]
机构
[1] Clin Univ St Luc, Gastroenterol, Brussels, Belgium
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P591
引用
收藏
页码:719 / 720
页数:2
相关论文
共 50 条
  • [21] Impact of Body Mass Index on Efficacy of Infliximab in Children With Inflammatory Bowel Disease
    Grossi, Victoria
    Lerer, Trudy
    Markowitz, James
    Griffiths, Anne M.
    Evans, Jonathan
    Bousvaros, Athos
    Mack, David R.
    Otley, Anthony R.
    Pfefferkorn, Marian D.
    Rosh, Joel R.
    Oliva-Hemker, Maria
    Saeed, Shehzad A.
    Deslandres, Colette
    Carvalho, Ryan
    Grossman, Andrew B.
    Keljo, David J.
    Kappelman, Michael
    Hitch, Meredith C.
    Sudel, Boris
    Rick, James
    Cabrera, Jose
    Faubion, William A.
    Leleiko, Neal S.
    Hyams, Jeffrey S.
    GASTROENTEROLOGY, 2013, 144 (05) : S128 - S128
  • [22] Cytomegalovirus, inflammatory bowel disease, and anti-TNFα
    Sara T. Campos
    Francisco A. Portela
    Luís Tomé
    International Journal of Colorectal Disease, 2017, 32 : 645 - 650
  • [23] Anti-TNF Treatment in Inflammatory Bowel Disease
    Yapali, Suna
    Hamzaoglu, Hulya Over
    ANNALS OF GASTROENTEROLOGY, 2007, 20 (01): : 48 - 53
  • [24] Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease
    Schultheiss, Johannes P. D.
    Mahmoud, Remi
    Louwers, Jonas M.
    van der Kaaij, Michiel T.
    van Hellemondt, Boris P.
    van Boeckel, Petra G.
    Mahmmod, Nofel
    Jharap, Bindia
    Fidder, Herma H.
    Oldenburg, Bas
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (10) : 1298 - 1308
  • [25] Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
    Eun, Chang Soo
    GUT AND LIVER, 2017, 11 (01) : 3 - 4
  • [26] Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases
    Guerra, Ivan
    Algaba, Alicia
    Lazaro Perez-Calle, Jose
    Chaparro, Maria
    Marin-Jimenez, Ignacio
    Garcia-Castellanos, Raquel
    Gonzalez-Lama, Yago
    Lopez-Sanroman, Antonio
    Mancenido, Noemi
    Martinez-Montiel, Pilar
    Quintanilla, Elvira
    Taxonera, Carlos
    Villafruela, Monica
    Romero-Mate, Alberto
    Lopez-Serrano, Pilar
    Gisbert, Javier P.
    Bermejo, Fernando
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (05): : 518 - 523
  • [27] Anti-TNF agents in patients with inflammatory bowel disease and malignant melanoma-challenges in management
    Lee, Jungmin
    Clarke, Kofi
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (12) : 1595 - 1602
  • [28] Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?
    Torres, Paola
    Canete, Fiorella
    Nunez, Laura
    Aguilar, Ariadna
    Mesonero, Francisco
    Calafat, Margalida
    Fernandez, Cristina
    Teniente, Aina
    Manosa, Miriam
    Lopez-Sanroman, Antonio
    Domenech, Eugeni
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (07) : 2036 - 2043
  • [29] Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?
    Paola Torres
    Fiorella Cañete
    Laura Núñez
    Ariadna Aguilar
    Francisco Mesonero
    Margalida Calafat
    Cristina Fernández
    Aïna Teniente
    Míriam Mañosa
    Antonio López-Sanromán
    Eugeni Domènech
    Digestive Diseases and Sciences, 2020, 65 : 2036 - 2043
  • [30] Spacing the administration interval of anti-TNF agents: a valid strategy for patients with inflammatory bowel disease?
    Torres, P.
    Nunez, L.
    Aguilar, A.
    Manosa, M.
    Mesonero, F.
    Canete, F.
    Calafat, M.
    Fernandez, C.
    Cabre, E.
    Lopez-Sanroman, A.
    Domenech, E.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S359 - S360